|
|
Article: M. D. ANDERSON STUDY OF CONCURRENT RADIOTHERAPY, CHEMOTHERAPY SHOWS PROMISE IN SMALL CELL LUNG CANCER
- Article from:
- US Fed News Service, Including US State News
- Article date:
- November 4, 2009
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
HOUSTON, Nov. 3 -- The University of Texas System of MD Anderson Cancer Center issued the following news release:
Treating limited stage small cell lung cancer (LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.
The phase II study was presented today (Nov. 3) in an oral session at the annual meeting of the American Society for Radiation Oncology (ASTRO), by Ritsuko Komaki, M.D., professor and program director of Lung Cancer Research and Thoracic Radiation Oncology, Division of Radiation Oncology at M. ...